NuVasive (NUVA +7.2%) shares are upgraded to Outperform by JMP Securities on signs that the...

|By:, SA News Editor

NuVasive (NUVA +7.2%) shares are upgraded to Outperform by JMP Securities on signs that the fundamentals of the slumping market for spine products have turned a corner. The firm says NUVA is well positioned to benefit from what should prove a long-term trend because of its focus on minimally invasive surgery and its acquisition of Impulse Monitoring.